| Application no. and date | 05853560.0 (espacenet) (Federated) (European Patent Register), 20051208 | | Patent/reg. no. and date | DK/EP 1819227, 20110209 | | Publication date | 20070822 | | Priority no. and date | US 9540, 20041210 | | EP pub. no. and date |
EP 1819227 20070822 | | Effective date | | | Applicant/owner | Astex Pharmaceuticals, Inc., 4420 Rosewood Drive, Suite 200
Pleasanton, CA 94588, US | | Applicant ref. no. | P18877DKEP | | Inventor | TANG, Chunlin, 135 Sharene Lane, 37
Walnut Creek, California 94596, US,
JOSHI-HANGAL, Rajashree, 1070 West Lagoon Road
Pleasanton, California 94566, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 31/724 (2006.01) , A61K 47/48 (2006.01) , A61P 3/00 (2006.01) , A61P 35/00 (2006.01) , A61P 9/10 (2006.01) | | Title | Farmaceutisk formulering af decitabin | | Int. application no. | US2005044676 | | Int. publication no. | WO2006071491 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
